澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

EPSILON HEALTHCARE LTD

0.022

0.000

成交量：- -

成交额：5,346.84

市值：856.03万

市盈率：-6.47

高：0.022

开：0.022

低：0.022

收：0.022

52周最高：0.040

52周最低：0.019

股本：3.89亿

流通股本：2.70亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.003

每股收益(LYR):-0.003

净资产收益率：-449.78%

总资产收益率：-9.65%

市净率：4.48

市盈率(LYR):-6.47

数据加载中...

总览公司新闻公告

Epsilon Healthcare：旗下Epsilon Pharma初始三年期制造业务收入预期达600万澳元

Epsilon Healthcare Ltd旗下Epsilon Pharma与Puro New Zealand达成制造协议助力欧洲市场拓展

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/EPN.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EPN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","market":"AU","secType":"STK","nameCN":"EPSILON HEALTHCARE LTD","latestPrice":0.022,"timestamp":1782259493624,"preClose":0.022,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"EPSILON HEALTHCARE LTD","floatShares":269789980,"shares":389104011,"eps":-0.0034,"marketStatus":"交易中","change":0,"latestTime":"06-24 10:04:53 AEST","open":0.022,"high":0.022,"low":0.022,"amount":5346.835999999999,"amplitude":0,"askPrice":0.023,"askSize":323719,"bidPrice":0.022,"bidSize":191042,"shortable":3,"etf":0,"ttmEps":-0.0034,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782280800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1782259200000,1782280800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EPN.AU","preClose":0.022,"auctionPrice":0.022,"auctionVolume":12200,"auctionTime":1782256461932,"referenceTime":1782212404120,"auction":1,"marketStatus":"盘前竞价","timestamp":1782256461932}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EPN.AU\",,,,,undefined,":{"symbol":"EPN.AU","floatShares":269789980,"roa":"-9.65%","roe":"-449.78%","lyrEps":-0.0034,"shares":389104011,"dividePrice":0,"high":0.022,"amplitude":0,"preClose":0.022,"low":0.022,"week52Low":0.019,"pbRate":"4.48","psRate":"0.91","week52High":0.04,"institutionHeld":0,"latestPrice":0.022,"committee":-0.257745,"eps":-0.0034,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0034,"open":0.022,"prevYearClose":0.033,"prevWeekClose":0.022,"prevMonthClose":0.024,"prevQuarterClose":0.021,"fiveDayClose":0.022,"twentyDayClose":0.022,"sixtyDayClose":0.021},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPN.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1175470333","title":"Epsilon Healthcare：旗下Epsilon Pharma初始三年期制造业务收入预期达600万澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175470333","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175470333?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 08:13","pubTimestamp":1770250404,"startTime":"0","endTime":"0","summary":"Epsilon Healthcare Ltd (ASX: EPN) 宣布，其子公司Epsilon Pharma在为期三年的初始合作期内，预计制造业务收入将达到600万澳元。这一预测凸显了公司在医药制造领域的增长潜力和业务稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","EPN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171456716","title":"Epsilon Healthcare Ltd旗下Epsilon Pharma与Puro New Zealand达成制造协议 助力欧洲市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=1171456716","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171456716?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 08:13","pubTimestamp":1770250398,"startTime":"0","endTime":"0","summary":"Epsilon Healthcare Ltd宣布，其子公司Epsilon Pharma已与新西兰企业Puro New Zealand签订新的制造合作协议。此项合作旨在为Epsilon Pharma在欧洲市场的扩张提供战略支持，通过强化供应链与本地化生产能力，提升其医药产品在欧洲的供应效率与市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","EPN.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}